Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Jivi for hemophilia A

Aug. 31, 2018

New preterm labor is drug safe with favorable pharmacokinetic profile

Aug. 31, 2018

PLIN2 is a putative tumor suppressor and prognostic marker of renal cell carcinoma

Aug. 31, 2018

Renin inhibitor TAK-272 developed at Takeda for heart failure

Aug. 31, 2018

Blincyto approved for use in pediatric patients with Ph- relapsed or refractory B-cell precursor ALL

Aug. 30, 2018

First patient dosed in phase II clinical trial in Duchenne muscular dystrophy

Aug. 30, 2018

Poxel acquires DRX-065 and portfolio of additional deuterated drug candidates

Aug. 30, 2018

Sophiris Bio announces update on phase IIb trial in localized prostate cancer

Aug. 30, 2018

Vertex and Genomics collaborate to advance discovery of precision medicines

Aug. 30, 2018

Lenvima capsules approved for first-line treatment of HCC in South Korea

Aug. 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...